JPH04279860A - 非洗浄型ディップスティック免疫学的検査装置 - Google Patents

非洗浄型ディップスティック免疫学的検査装置

Info

Publication number: JPH04279860A
Authority: JP; Japan
Prior art keywords: immunological; enzyme; zone; test device; antibody
Prior art date: 1990-01-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

JP2412006A

Other languages

English (en)

Japanese (ja)

Inventor

Jemo Kang

ジェモ・カン

John A Colanduoni

ジョン・エイ・コランドゥオーニ

Dong Joon Lee

ドン・ジュン・リー

Byungwoo Youn

ビョンウ・ユン

Chiyoung Ok

チャン・オク

Walter J Kang

ウォーター・ジェイ・カン

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

MYUON CO Ltd

Princeton Biomeditech Corp

Original Assignee

MYUON CO Ltd

Princeton Biomeditech Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-01-10

Filing date

1990-12-18

Publication date

1992-10-05

1990-12-18 Application filed by MYUON CO Ltd, Princeton Biomeditech Corp filed Critical MYUON CO Ltd

1992-10-05 Publication of JPH04279860A publication Critical patent/JPH04279860A/ja

Status Pending legal-status Critical Current

Links

238000003018 immunoassay Methods 0.000 title description 8
238000004140 cleaning Methods 0.000 title description 4
238000012360 testing method Methods 0.000 claims abstract description 60
239000000758 substrate Substances 0.000 claims abstract description 34
230000001900 immune effect Effects 0.000 claims abstract description 30
102000004190 Enzymes Human genes 0.000 claims abstract description 28
108090000790 Enzymes Proteins 0.000 claims abstract description 28
229940088598 enzyme Drugs 0.000 claims description 26
239000012491 analyte Substances 0.000 claims description 21
239000000427 antigen Substances 0.000 claims description 16
102000036639 antigens Human genes 0.000 claims description 16
108091007433 antigens Proteins 0.000 claims description 16
102000002260 Alkaline Phosphatase Human genes 0.000 claims description 5
108020004774 Alkaline Phosphatase Proteins 0.000 claims description 5
239000004677 Nylon Substances 0.000 claims description 4
229920001778 nylon Polymers 0.000 claims description 4
108010015776 Glucose oxidase Proteins 0.000 claims description 3
239000004366 Glucose oxidase Substances 0.000 claims description 3
102000003855 L-lactate dehydrogenase Human genes 0.000 claims description 3
108700023483 L-lactate dehydrogenases Proteins 0.000 claims description 3
239000000020 Nitrocellulose Substances 0.000 claims description 3
229940116332 glucose oxidase Drugs 0.000 claims description 3
235000019420 glucose oxidase Nutrition 0.000 claims description 3
229920001220 nitrocellulos Polymers 0.000 claims description 3
102100031126 6-phosphogluconolactonase Human genes 0.000 claims description 2
108010029731 6-phosphogluconolactonase Proteins 0.000 claims description 2
108010089254 Cholesterol oxidase Proteins 0.000 claims description 2
108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 claims description 2
102000016943 Muramidase Human genes 0.000 claims description 2
108010014251 Muramidase Proteins 0.000 claims description 2
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 2
102000003992 Peroxidases Human genes 0.000 claims description 2
108010046334 Urease Proteins 0.000 claims description 2
229920002678 cellulose Polymers 0.000 claims description 2
239000001913 cellulose Substances 0.000 claims description 2
239000011152 fibreglass Substances 0.000 claims description 2
239000011521 glass Substances 0.000 claims description 2
229960000274 lysozyme Drugs 0.000 claims description 2
239000004325 lysozyme Substances 0.000 claims description 2
235000010335 lysozyme Nutrition 0.000 claims description 2
108040007629 peroxidase activity proteins Proteins 0.000 claims description 2
239000004033 plastic Substances 0.000 claims description 2
229920002492 poly(sulfone) Polymers 0.000 claims description 2
229920000728 polyester Polymers 0.000 claims description 2
229920002981 polyvinylidene fluoride Polymers 0.000 claims description 2
102000002464 Galactosidases Human genes 0.000 claims 1
108010093031 Galactosidases Proteins 0.000 claims 1
239000000126 substance Substances 0.000 abstract description 7
230000015572 biosynthetic process Effects 0.000 abstract description 2
239000000243 solution Substances 0.000 description 18
239000012528 membrane Substances 0.000 description 11
238000000034 method Methods 0.000 description 11
239000007787 solid Substances 0.000 description 7
210000002700 urine Anatomy 0.000 description 7
229940084986 human chorionic gonadotropin Drugs 0.000 description 5
239000007790 solid phase Substances 0.000 description 5
102000009151 Luteinizing Hormone Human genes 0.000 description 4
108010073521 Luteinizing Hormone Proteins 0.000 description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
229940040129 luteinizing hormone Drugs 0.000 description 4
239000000047 product Substances 0.000 description 4
102000011022 Chorionic Gonadotropin Human genes 0.000 description 3
108010062540 Chorionic Gonadotropin Proteins 0.000 description 3
102000006771 Gonadotropins Human genes 0.000 description 3
108010086677 Gonadotropins Proteins 0.000 description 3
230000000890 antigenic effect Effects 0.000 description 3
239000013060 biological fluid Substances 0.000 description 3
239000002622 gonadotropin Substances 0.000 description 3
230000000984 immunochemical effect Effects 0.000 description 3
238000011534 incubation Methods 0.000 description 3
238000007689 inspection Methods 0.000 description 3
239000007788 liquid Substances 0.000 description 3
239000000463 material Substances 0.000 description 3
239000011148 porous material Substances 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
238000005406 washing Methods 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
QRXMUCSWCMTJGU-UHFFFAOYSA-N 5-bromo-4-chloro-3-indolyl phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP(O)(=O)O)=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-N 0.000 description 2
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
241001494479 Pecora Species 0.000 description 2
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
239000007983 Tris buffer Substances 0.000 description 2
IOMLBTHPCVDRHM-UHFFFAOYSA-N [3-[(2,4-dimethylphenyl)carbamoyl]naphthalen-2-yl] dihydrogen phosphate Chemical compound CC1=CC(C)=CC=C1NC(=O)C1=CC2=CC=CC=C2C=C1OP(O)(O)=O IOMLBTHPCVDRHM-UHFFFAOYSA-N 0.000 description 2
102000005936 beta-Galactosidase Human genes 0.000 description 2
108010005774 beta-Galactosidase Proteins 0.000 description 2
YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
229920002301 cellulose acetate Polymers 0.000 description 2
239000003153 chemical reaction reagent Substances 0.000 description 2
230000002860 competitive effect Effects 0.000 description 2
239000003431 cross linking reagent Substances 0.000 description 2
229940094892 gonadotropins Drugs 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical group C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 2
239000002244 precipitate Substances 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
QLAJNZSPVITUCQ-UHFFFAOYSA-N 1,3,2-dioxathietane 2,2-dioxide Chemical compound O=S1(=O)OCO1 QLAJNZSPVITUCQ-UHFFFAOYSA-N 0.000 description 1
KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 description 1
JTNGEYANGCBZLK-UHFFFAOYSA-N 1h-indol-3-yl dihydrogen phosphate Chemical compound C1=CC=C2C(OP(O)(=O)O)=CNC2=C1 JTNGEYANGCBZLK-UHFFFAOYSA-N 0.000 description 1
VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 description 1
UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 1
HSTOKWSFWGCZMH-UHFFFAOYSA-N 3,3'-diaminobenzidine Chemical compound C1=C(N)C(N)=CC=C1C1=CC=C(N)C(N)=C1 HSTOKWSFWGCZMH-UHFFFAOYSA-N 0.000 description 1
LLARVKAOQLUCQI-UHFFFAOYSA-L 4-benzamido-2,5-dimethoxybenzenediazonium;tetrachlorozinc(2-) Chemical compound [Cl-].[Cl-].Cl[Zn]Cl.COC1=CC([N+]#N)=C(OC)C=C1NC(=O)C1=CC=CC=C1.COC1=CC([N+]#N)=C(OC)C=C1NC(=O)C1=CC=CC=C1 LLARVKAOQLUCQI-UHFFFAOYSA-L 0.000 description 1
KIWIFIXMWIMRBZ-UHFFFAOYSA-L 4-benzamido-2-methoxy-5-methylbenzenediazonium;dichlorozinc;dichloride Chemical compound [Cl-].[Cl-].Cl[Zn]Cl.C1=C([N+]#N)C(OC)=CC(NC(=O)C=2C=CC=CC=2)=C1C.C1=C([N+]#N)C(OC)=CC(NC(=O)C=2C=CC=CC=2)=C1C KIWIFIXMWIMRBZ-UHFFFAOYSA-L 0.000 description 1
LVSPDZAGCBEQAV-UHFFFAOYSA-N 4-chloronaphthalen-1-ol Chemical compound C1=CC=C2C(O)=CC=C(Cl)C2=C1 LVSPDZAGCBEQAV-UHFFFAOYSA-N 0.000 description 1
OXEUETBFKVCRNP-UHFFFAOYSA-N 9-ethyl-3-carbazolamine Chemical compound NC1=CC=C2N(CC)C3=CC=CC=C3C2=C1 OXEUETBFKVCRNP-UHFFFAOYSA-N 0.000 description 1
102100023635 Alpha-fetoprotein Human genes 0.000 description 1
108090001008 Avidin Proteins 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
240000006497 Dianthus caryophyllus Species 0.000 description 1
235000009355 Dianthus caryophyllus Nutrition 0.000 description 1
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
108010001336 Horseradish Peroxidase Proteins 0.000 description 1
108060003951 Immunoglobulin Proteins 0.000 description 1
108010048733 Lipozyme Proteins 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
AODGGAXCSNLSHI-UHFFFAOYSA-N [3-[(2-methylphenyl)carbamoyl]anthracen-2-yl] dihydrogen phosphate Chemical compound CC1=CC=CC=C1NC(=O)C1=CC2=CC3=CC=CC=C3C=C2C=C1OP(O)(O)=O AODGGAXCSNLSHI-UHFFFAOYSA-N 0.000 description 1
MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 1
238000004026 adhesive bonding Methods 0.000 description 1
108010026331 alpha-Fetoproteins Proteins 0.000 description 1
238000003556 assay Methods 0.000 description 1
238000003149 assay kit Methods 0.000 description 1
239000011324 bead Substances 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
239000008366 buffered solution Substances 0.000 description 1
-1 but not limited to Substances 0.000 description 1
239000000969 carrier Substances 0.000 description 1
238000002967 competitive immunoassay Methods 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
238000001514 detection method Methods 0.000 description 1
230000000694 effects Effects 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
239000003365 glass fiber Substances 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
239000010931 gold Substances 0.000 description 1
229910052737 gold Inorganic materials 0.000 description 1
229940127121 immunoconjugate Drugs 0.000 description 1
102000018358 immunoglobulin Human genes 0.000 description 1
229940027941 immunoglobulin g Drugs 0.000 description 1
235000019239 indanthrene blue RS Nutrition 0.000 description 1
UHOKSCJSTAHBSO-UHFFFAOYSA-N indanthrone blue Chemical compound C1=CC=C2C(=O)C3=CC=C4NC5=C6C(=O)C7=CC=CC=C7C(=O)C6=CC=C5NC4=C3C(=O)C2=C1 UHOKSCJSTAHBSO-UHFFFAOYSA-N 0.000 description 1
230000003993 interaction Effects 0.000 description 1
FCCDDURTIIUXBY-UHFFFAOYSA-N lipoamide Chemical compound NC(=O)CCCCC1CCSS1 FCCDDURTIIUXBY-UHFFFAOYSA-N 0.000 description 1
239000002502 liposome Substances 0.000 description 1
229910001629 magnesium chloride Inorganic materials 0.000 description 1
238000013508 migration Methods 0.000 description 1
230000005012 migration Effects 0.000 description 1
230000001617 migratory effect Effects 0.000 description 1
VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
DDRCIGNRLHTTIW-UHFFFAOYSA-N n-(4-amino-2,5-dimethoxyphenyl)benzamide Chemical compound C1=C(N)C(OC)=CC(NC(=O)C=2C=CC=CC=2)=C1OC DDRCIGNRLHTTIW-UHFFFAOYSA-N 0.000 description 1
239000002245 particle Substances 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
239000008055 phosphate buffer solution Substances 0.000 description 1
239000002985 plastic film Substances 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
235000008476 powdered milk Nutrition 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
238000000746 purification Methods 0.000 description 1
INCIMLINXXICKS-UHFFFAOYSA-M pyronin Y Chemical compound [Cl-].C1=CC(=[N+](C)C)C=C2OC3=CC(N(C)C)=CC=C3C=C21 INCIMLINXXICKS-UHFFFAOYSA-M 0.000 description 1
BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
238000011896 sensitive detection Methods 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
239000008279 sol Substances 0.000 description 1
238000005507 spraying Methods 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
238000010998 test method Methods 0.000 description 1
230000000007 visual effect Effects 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Food Science & Technology (AREA)
General Physics & Mathematics (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Microbiology (AREA)
Pathology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Investigating Or Analysing Biological Materials (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Apparatus Associated With Microorganisms And Enzymes (AREA)
Sampling And Sample Adjustment (AREA)

JP2412006A 1990-01-10 1990-12-18 非洗浄型ディップスティック免疫学的検査装置 Pending JPH04279860A (ja)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US46282790A	1990-01-10	1990-01-10
US462827		1990-01-10

Publications (1)

Publication Number	Publication Date
JPH04279860A true JPH04279860A (ja)	1992-10-05

Family

ID=23837914

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2412006A Pending JPH04279860A (ja)	1990-01-10	1990-12-18	非洗浄型ディップスティック免疫学的検査装置

Country Status (7)

Country	Link
JP (1)	JPH04279860A (fr)
KR (1)	KR910014705A (fr)
AU (1)	AU644098B2 (fr)
CH (1)	CH683379A5 (fr)
DE (1)	DE4037736A1 (fr)
FR (1)	FR2656927B1 (fr)
IT (1)	IT1242791B (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2008501124A (ja) *	2004-06-01	2008-01-17	ウーメディックインコーポレーテッド	マクロおよびミクロマトリックスの迅速な検出および定量方法および装置
JP4988546B2 (ja) *	2005-01-28	2012-08-01	持田製薬株式会社	イムノクロマト用試験具およびこれを用いた半定量方法
WO2019221250A1 (fr) *	2018-05-17	2019-11-21	株式会社テクノメデイカ	Procédé d'analyse immunochromatographique compétitive et capteur immunochromatographique

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR910014706A (ko) *	1990-01-10	1991-08-31	원본미기재	세척이 필요없는 개량된 이뮤노어세이(immunoassay)장치
DE4229591C1 (de) *	1992-09-04	1994-03-24	Draegerwerk Ag	Immunologisches Verfahren zur Bestimmung eines Analyten

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3269567D1 (en) *	1981-04-29	1986-04-10	Ciba Geigy Ag	New devices and kits for immunological analysis
AU2706384A (en) *	1983-05-06	1984-11-08	Monoclonal Antibodies Inc.	Colorimetric immunoassay on solid surface
US4649121A (en) *	1985-02-26	1987-03-10	Miles Laboratories, Inc.	Viability test device
US4916056A (en) *	1986-02-18	1990-04-10	Abbott Laboratories	Solid-phase analytical device and method for using same
ATE129346T1 (de) *	1987-08-05	1995-11-15	Calypte Inc	Teststreifen für diagnose durch multi-immunoassay system.
KR910014706A (ko) *	1990-01-10	1991-08-31	원본미기재	세척이 필요없는 개량된 이뮤노어세이(immunoassay)장치

1990
- 1990-05-07 KR KR1019900006411A patent/KR910014705A/ko not_active Ceased
- 1990-08-08 IT IT06762890A patent/IT1242791B/it active IP Right Grant
- 1990-09-24 AU AU63108/90A patent/AU644098B2/en not_active Ceased
- 1990-11-09 FR FR9013895A patent/FR2656927B1/fr not_active Expired - Fee Related
- 1990-11-27 DE DE4037736A patent/DE4037736A1/de not_active Ceased
- 1990-12-12 CH CH3939/90A patent/CH683379A5/fr not_active IP Right Cessation
- 1990-12-18 JP JP2412006A patent/JPH04279860A/ja active Pending

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2008501124A (ja) *	2004-06-01	2008-01-17	ウーメディックインコーポレーテッド	マクロおよびミクロマトリックスの迅速な検出および定量方法および装置
JP4988546B2 (ja) *	2005-01-28	2012-08-01	持田製薬株式会社	イムノクロマト用試験具およびこれを用いた半定量方法
WO2019221250A1 (fr) *	2018-05-17	2019-11-21	株式会社テクノメデイカ	Procédé d'analyse immunochromatographique compétitive et capteur immunochromatographique
JPWO2019221250A1 (ja) *	2018-05-17	2021-11-11	株式会社テクノメデイカ	競合イムノクロマト分析法及びイムノクロマトセンサ
US12188928B2 (en)	2018-05-17	2025-01-07	Techno Medica Co., Ltd.	Competitive immunochromatographic analysis method and immunochromatographic sensor

Also Published As

Publication number	Publication date
DE4037736A1 (de)	1991-07-11
AU6310890A (en)	1991-07-11
IT1242791B (it)	1994-05-18
FR2656927A1 (fr)	1991-07-12
CH683379A5 (fr)	1994-02-28
IT9067628A1 (it)	1992-02-08
KR910014705A (ko)	1991-08-31
AU644098B2 (en)	1993-12-02
IT9067628A0 (it)	1990-08-08
FR2656927B1 (fr)	1997-01-10

Publication	Publication Date	Title
US5656448A (en)	1997-08-12	Dipstick immunoassay device
US5158869A (en)	1992-10-27	Analyte determination using comparison of juxtaposed competitive and non-competitive elisa results and device therefore
JP3333755B2 (ja)	2002-10-15	免疫化学的標識およびこれを含有する水性懸濁液、ならびに該免疫化学的標識の製造方法
EP0250137B1 (fr)	1992-08-26	Essai immunologique utilisant de l'or colloidal
US4912034A (en)	1990-03-27	Immunoassay test device and method
EP0462376B1 (fr)	1996-07-24	Essais faisant intervenir de liaisons avec récupération de conjugue
EP0335244B1 (fr)	1994-12-28	Dispositif d'analyse en phase solide et procédé pour son utilisation
EP0389003B1 (fr)	1992-12-09	Dispositif analytique en phase solide et procédé pour son utilisation
US7569397B2 (en)	2009-08-04	Immunoassay devices and use thereof
JP3135067B2 (ja)	2001-02-13	免疫診断検査系およびその利用
US20070224701A1 (en)	2007-09-27	Combination vertical and lateral flow immunoassay device
JPH0449657B2 (fr)	1992-08-12
US20070020769A1 (en)	2007-01-25	Immunoassay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients
JPH01245157A (ja)	1989-09-29	免疫分折用キット
EP1081496A1 (fr)	2001-03-07	Essai au passage continu de fluide pour la détection visuelle de la présence de l'influenza A et B
US5063151A (en)	1991-11-05	Immunoassay method and kit
JPH04279860A (ja)	1992-10-05	非洗浄型ディップスティック免疫学的検査装置
US7109023B2 (en)	2006-09-19	Immunossay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients
GB2241329A (en)	1991-08-28	Sandwich type immunoassay
EP0200767A1 (fr)	1986-11-12	Essai immunologique a liaison double d'antigenes impliques dans des affections des yeux.
JPH0283448A (ja)	1990-03-23	免疫測定方法